Human relaxin-2: Historical perspectives and role in cancer biology

Amino Acids

Volumn 43, Issue 3, 2012, Pages 1131-1140

  Nair, Vinojini B ^a   Samuel, Chrishan S ^a,b   Separovic, Frances ^a   Hossain, Mohammed Akhter ^a   Wade, John D ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Cancer; H2 relaxin; Relaxin; RXFP1; Tumour development

Indexed keywords

G PROTEIN COUPLED RECEPTOR; INSULIN; LENTIVIRUS VECTOR; NITRIC OXIDE; RELAXIN; RELAXIN 3; RELAXIN FAMILY PEPTIDE RECEPTOR 1; RELAXIN FAMILY PEPTIDE RECEPTOR 2; RELAXIN FAMILY PEPTIDE RECEPTOR 3; RELAXIN FAMILY PEPTIDE RECEPTOR 4; SERELAXIN; UNCLASSIFIED DRUG;

ACUTE HEART FAILURE; ANTINEOPLASTIC ACTIVITY; BREAST CANCER; CANCER CELL; CELL GROWTH; CELL INVASION; CELL PROLIFERATION; DRUG EFFECT; HUMAN; METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; TUMOR VASCULARIZATION; VASODILATATION;

AMINO ACID SEQUENCE; ANIMALS; ANTINEOPLASTIC AGENTS; CONSERVED SEQUENCE; EVOLUTION, MOLECULAR; HUMANS; INSULINS; MOLECULAR SEQUENCE DATA; MOLECULAR TARGETED THERAPY; NEOPLASMS; PROTEIN CONFORMATION; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, PEPTIDE; RELAXIN;

EID: 84867061771     PISSN: 09394451     EISSN: 14382199     Source Type: Journal    
DOI: 10.1007/s00726-012-1375-y     Document Type: Review

References (88)

1. Adham IM, Burkhardt E, Benahmed M (1993) Cloning of a cDNA for a novel insulin-like peptide of the testicular Leydig cells. J Biol Chem 268:26668-26672 (Pubitemid 23361751)
2. Bani G, Bigazzi M (1984) Morphological changes induced in mouse mammary gland by porcine and human relaxin. Acta Anat 119:149-154 (Pubitemid 14111947)
3. Bani D, Masini E, Bello MG, Bigazzi M, Sacchi TB (1995) Relaxin activates the L-arginine-nitric oxide pathway in human breast cancer cells. Cancer Res 55:5272-5275
4. Bani D, Flagiello D, Poupon MF, Nistri S, Poirson-Birhcat F, Bigazzi M, Bani G, Sacchi TB (1999a) Relaxin promotes differentiation of human breast cancer cells MCF-7 transplanted into nude mice. Virchows Arch 435:509-519. doi:10.1007/s004280050435
5. Bani D, Baccari MC, Nistri S, Calamai F, Bigazzi M, Sacchi TB (1999b) Relaxin up-regulates the nitric oxide biosynthetic pathway in the mouse uterus: involvement in the inhibition of myometrial contractility. Endocrinology 140:4434-4441. doi: 10.1210/en.140.10.4434 (Pubitemid 30666106)
6. Barrett-Connor E, Garland C, McPhillips JB, Khaw KT, Wingard DL (1990) A prospective, population-based study of androstenedione, estrogens, and prostatic cancer. Cancer Res 50:169-173 (Pubitemid 20030013)
7. Bathgate RAD (2006) Relaxin-3: improved synthesis strategy and demonstration of its high-affinity interaction with the relaxin receptor LGR7 both in vitro and in vivo. Biochemistry 45:1043-1053. doi:10.1021/bi052233e (Pubitemid 43122269)
8. Bathgate R, Hsueh A, Sherwood OD (2006a) Physiology and molecular biology of the relaxin peptide family. In: Neill JD (ed) Knobil and Neills physiology of reproduction, 3rd edn. Academic Press, San Diego, pp 679-768
9. Bathgate RAD, Ivell R, Sanborn BM, Sherwood OD, Summers RJ (2006b) International Union of Pharmacology LVII: recommendations for the nomenclature of receptors for relaxin family peptides. Pharmacol Rev 58:7-31. doi:10.1124/pr.58.1.9
10. Belgi A, Hossain MA, Shabanpoor F, Zhang S, Bathgate RAD, Tregear GW, Wade JD (2011) Structure and function relationship of murine insulin-like peptide 5 (INSL5): free C-terminus is essential for RXFP4 receptor binding and activation. Biochemistry 50:8352-8361
11. Bellet D, Lavaissiere L, Mock P, Laurent A, Sabourin JC, Bedossa P, Le Bouteiller P, Frydman R, Troalen F, Bidart J (1997) Identification of pro-EPIL and EPIL peptides translated from insulin-like 4 (INSL4) mRNA in human placenta. J Clin Endocrinol Metab 82:3169-3172 (Pubitemid 27385694)
12. Binder C, Binder L, Gurlit L, Einspanier A (2001) High serum concentrations of relaxin correlate with dissemination of breast cancer. In: Tregear GW, Ivell R, Bathgate RA, Wade JD (eds) Relaxin 2000. Kluwer Academic Publishers, Netherlands, pp 423-432
13. Binder C, Hagemann T, Husen B, Schulz M, Einspanier A (2002) Relaxin enhances in vitro invasiveness of breast cancer cell lines by up-regulation of matrix metalloproteases. MHR Basic Sci Reprod Med 8:789-796. doi:10.1093/molehr/8.9.789 (Pubitemid 35012465)
14. Binder C, Simon A, Binder L, Hagemann T, Schulz M, Emons G, Trumper L, Einspanier A (2004) Elevated concentrations of serum relaxin are associated with metastatic disease in breast cancer patients. Breast Cancer Res Treat 87:157-166. doi: 10.1023/b:brea.0000041622.30169.16 (Pubitemid 39237792)
15. Brener SHL, Schoenfeld C, Amelar RD, Dubin L, Weiss G (1984) Stimulation of human sperm cervical mucus penetration in vitro by relaxin. Fertil Steril 42:92-96 (Pubitemid 14086157)
16. Büllesbach EE, Schwabe C (2000) The relaxin receptor-binding site geometry suggests a novel gripping mode of interaction. J Biol Chem 275:35276-35280. doi:10.1074/jbc.M005728200
17. Büllesbach EE, Schwabe C (2001) Synthesis and conformational analysis of the insulin-like 4 gene product. J Pept Res 57:77-83 (Pubitemid 32057832)
18. Büllesbach EE, Schwabe C (2002) The primary structure and the disulfide links of the bovine relaxin-like factor (RLF). Biochemistry 41:274-281. doi:10.1021/bi0117302 (Pubitemid 34049404)
19. Burger LL, Sherwood OD (1998) Relaxin increases the accumulation of new epithelial and stromal cells in the rat cervix during the second half of pregnancy. Endocrinology 139:3984-3995. doi: 10.1210/en.139.9.3984 (Pubitemid 28512282)
20. Chan LJ, Hossain MA, Samuel CS, Separovic F, Wade JD (2011) The relaxin peptide family-structure, function and clinical applications. Protein Pept Lett 18:220-229
21. Conrad KP, Novak J (2004) Emerging role of relaxin in renal and cardiovascular function. Am J Physiol Regul Integr Comp Physiol 287:250-261. doi:10.1152/ajpregu.00672.2003 (Pubitemid 38970272)
22. Dschietzig T, Bartsch C, Baumann G, Stangl K (2006) Relaxin-a pleiotropic hormone and its emerging role for experimental and clinical therapeutics. Pharm Ther 112:38-56. doi:10.1016/j. pharmthera.2006.03.004 (Pubitemid 44301484)
23. Eigenbrot C, Randal M, Quan C, Burnier J, OConnell L, Rinderknecht E, Kossiakoff AA (1991) X-ray structure of human relaxin at 1.5 A. Comparison to insulin and implications for receptor binding determinants. J Mol Biol 221(1):15-21 (Pubitemid 121003550)
24. Eppel W, Kucera E, Bielglmyer C (1999) Relationship of serum levels of endogenous relaxin to cervical size in the second trimester and to cervical ripening at term. Br J Obstet Gynaecol 106:917-923 (Pubitemid 29415621)
25. Failli P, Nistri S, Quattrone S, Mazzetti L, Bigazzi M, Sacchi TB, Bani D (2002) Relaxin up-regulates inducible nitric oxide synthase expression and nitric oxide generation in rat coronary endothelial cells. FASEB J 16:252-254
26. Feng S, Agoulnik A (2011) Expression of LDL-A module of relaxin receptor in prostate cancer cells inhibits tumorigenesis. Int J Oncol 39:1559-1565
27. Feng S, Agoulnik IU, Bogatcheva NV, Kamat AA, Kwabi-Addo B, Li R, Ayala G, Ittmann MM, Agoulnik AI (2007) Relaxin promotes prostate cancer progression. Clinical Cancer Res 13:1695-1702. doi:10.1158/1078-0432.ccr-06-2492 (Pubitemid 46952934)
28. Ferlin A, Pepe A, Gianesello L, Garolla A, Feng S, Facciolli A, Morello R, Agoulnik AI, Foresta C (2009) New roles for INSL3 in adults. Ann N Y Acad Sci 1160:215-218. doi:10.1111/ j.1749-6632.2008.03787.x
29. Friedman A (2003) Remembrance: the contributions of Frederick Hisaw. J Clin Endocrinol Metab 88:524-527. doi: 10.1210/jc.2002-021457
30. Gunnersen JM, Roche PJ, Tregear GW, Crawford RJ (1995) Characterization of human relaxin gene regulation in the relaxin-expressing human prostate adenocarcinoma cell line LNCaP.FGC. J Mol Endocrinol 15:153-166. doi:10.1677/jme. 0.0150153
31. Hansell DJ, Bryant-Greenwood GD, Greenwood FC (1991) Expression of the human relaxin H1 gene in the decidua, trophoblast, and prostate. J Clin Endocrinol Metab 72:899-904. doi: 10.1210/jcem-72-4-899 (Pubitemid 21921783)
32. Hisaw F (1926) Experimental relaxation of the pubic ligament of the guinea pig. Proc Soc Exper Biol Med 23:661-663
33. Hombach-Klonisch S, Bialek J, Trojanowicz B, Weber E, Holzhausen HJ, Silvertown JD, Summerlee AJ, Dralle H, Hoang-Vu C, Klonisch T (2006) Relaxin enhances the oncogenic potential of human thyroid carcinoma cells. Am J Pathol 169:617-632. doi: 10.2353/ajpath.2006.050876 (Pubitemid 44156318)
34. Hossain MA, Wade JD (2010) The roles of the A- and B-chains of human relaxin-2 and -3 on their biological activity. Curr Protein Pept Sci 11:719-724
35. Hossain MA, Bathgate RA, Kong C, Shabanpoor F, Zhang S, Haugaard-Jönsson LM, Rosengren KJ, Tregear GW, Wade JD (2008) Synthesis, conformation and receptor binding activity of human insulin-like peptide 5 (INSL5). ChemBioChem 9:1816-1822
36. Hossain MA, Samuel CS, Binder C, Hewitson TD, Tregear GW, Wade JD, Bathgate RAD (2010) The chemically synthesized human relaxin-2 analog, B-R13/17K H2, is an RXFP1 antagonist. Amino Acids 39:409-416. doi:10.1007/s00726-009- 0454-1
37. Hossain MA, Chow BSM, Zhao C, Xu Q, Du XJ, Wade JD, Samuel CS (2011) H3 relaxin demonstrates antifibrotic properties via the RXFP1 receptor. Biochemistry 50:1368-1375. doi:10.1021/ bi1013968
38. Hsu SY (1999) Cloning of two novel mammalian paralogs of relaxin/ insulin family proteins and their expression in testis and kidney. Mol Endocrinol 13:2163-2167. doi:10.1210/me.13.12.2163
39. Hsu SY, Nakabayashi K, Nishi S, Kumagai J, Kudo M, Sherwood OD, Hsueh AJW (2002) Activation of orphan receptors by the hormone relaxin. Science 295:671-674 (Pubitemid 34111824)
40. Hwang JJ, Shanks RD, Sherwood OD (1989) Monoclonal antibodies specific for rat relaxin. IV. Passive immunization with monoclonal antibodies during the antepartum period reduces cervical growth and extensibility, disrupts birth, and reduces pup survival in intact rats. Endocrinology 125:260-266. doi:10.1210/endo- 125-1-260 (Pubitemid 19182668)
41. Ivell R, Hunt N, Khan-Dawood F, Dawood MY (1989) Expression of the human relaxin gene in the corpus luteum of the menstrual cycle and in the prostate. Mol Cellular Endocrinol 66:251-255. doi:10.1016/0303-7207(89)90037-3 (Pubitemid 19253395)
42. Ivell R, Hartung S, Anand-Ivell R (2005) Insulin-like factor 3: where are we now? Ann NY Acad Sci 1041:486-496. doi:10.1196/ annals.1282.073 (Pubitemid 41132290)
43. Jadeski LC, Hum KO, Chakraborty C, Lala PK (2000) Nitric oxide promotes murine mammary tumour growth and metastasis by stimulating tumour cell migration, invasiveness and angiogenesis. Int J Cancer 86:30-39. doi:10.1002/(sici)1097-0215 (20000401)86:1\30::aid-ijc5[3.0.co;2-i (Pubitemid 30133983)
44. Jadeski LC, Chakraborty C, Lala PK (2003) Nitric oxide-mediated promotion of mammary tumour cell migration requires sequential activation of nitric oxide synthase, guanylate cyclase and mitogen-activated protein kinase. Int J Cancer 106:496. doi: 10.1002/ijc.11268 (Pubitemid 36966204)
45. Johnson MR, Abdalla H, Allman AC, Wren ME, Kirkland A, Lighman SL (1991) Relaxin levels in ovum donation pregnancies. Fertil Steril 56:59-61
46. Kamat AA, Feng S, Agoulnik IU, Kheradmand F, Bogatcheva NV, Coffey D, Sood AK, Agoulnik AI (2006) The role of relaxin in endometrial cancer. Cancer Biol Therap 5:71-77. doi: 10.4161/cbt.5.1.2289 (Pubitemid 43234981)
47. Kawamura K, Kumagai J, Sudo S, Chun SY, Pisarska M, Morita H, Toppari J, Fu P, Wade JD, Bathgate RAD, Hsueh AJ (2004) Paracrine regulation of mammalian oocyte maturation and male germ cell survival. Proc Natl Acad Sci USA 101:7323-7328. doi:10.1073/pnas.0307061101 (Pubitemid 38638031)
48. Kong RCK, Shiling PJ, Lobb DK, Gooley PR, Bathgate RAD (2010) Membrane receptors: structure and function of the relaxin family peptide receptors. Mol Cell Endocrinol 320:1-15. doi:10.1016/ j.mce.2010.02.003
49. Kumagai J, Hsu SY, Matsumi H, Roh JS, Fu P, Wade JD, Bathgate RAD, Hsueh AJ (2002) INSL3/Leydig insulin-like peptide activates the LGR8 receptor important in testis descent. J Biol Chem 277:31283-31286. doi:10.1074/jbc. C200398200 (Pubitemid 34968925)
50. Laurent A, Rouillac C, Delezoide AL, Giovangrandi Y, Vekemans M, Bellet D, Abitbol M, Vidaud M (1998) Insulin-like 4 (INSL4) gene expression in human embryonic and trophoblastic tissues. Mol Reprod Dev 51:123-129. doi:10.1002/(sici)1098-2795 (199810)51:2\123:aid-mrd1[3.0.co2-s (Pubitemid 28420575)
51. Liang WC, Wu X, Peale FV, Lee CV, Meng YG, Gutierrez J, Fu L, Malik AK, Gerber HP, Ferrara N, Fuh G (2006) Cross-species vascular endothelial growth factor (VEGF)-blocking antibodies completely inhibit the growth of human tumor xenografts and measure the contribution of stromal VEGF. J Biol Chem 281: 951-961. doi:10.1074/jbc.M508199200
52. Lin F, Otvos L Jr, Kumagai J, Tregear GW, Bathgate RA, Wade JD (2004) Synthetic human insulin 4 does not activate the G-protein- coupled receptors LGR7 or LGR8. J Pept Sci 10:257-264. doi:10.1002/psc.521 (Pubitemid 38594186)
53. Liu C, Lovenberg T (2008) Relaxin-3, INSL5, and their receptors. Orphan G protein-coupled receptors and novel neuropeptides. Results Probl Cell Differ 46:213-237. doi:10.1007/400-2007-055
54. Liu C, Eriste E, Sutton S (2003) Identification of relaxin-3/INSL7 as an endogenous ligand for the orphan G-protein-coupled receptor GPCR135. J Biol Chem 278:50754-50764. doi:10.1074/jbc. M308995200 (Pubitemid 37548924)
55. Lok S, Johnston DS, Conklin D, Lofton-Day CE, Adams RL, Jelmberg AC, Whitmore TE, Schrader S, Grisworld MD, Jaspers SR (2000) Identification of INSL6, a new member of the insulin family that is expressed in the testis of the human and rat. Biol Reprod 62:1593-1599. doi:10.1095/biolreprod62.6.1593 (Pubitemid 30333740)
56. Lu CX, Walker WH, Sun J, Weisz OA, Gibbs RB, Witchel SF, Sperling MA, Menon RK (2006) Insulin-like peptide 6: characterization of secretory status and posttranslational modifications. Endocrinology 147:5611-5623. doi:10.1210/en.2006-0503 (Pubitemid 44833478)
57. Luo X, Bathgate RAD, Zhang W-J, Liu Y-L, Shao X-X, Wade JD, Guo Z-Y (2010) Design and recombinant expression of insulinlike peptide 5 (INSL5) precursors and the preparation of mature human INSL5. Amino Acids 39:1343-1352
58. Ma S, Gundlach AL (2007) Relaxin-family peptide and receptor systems in brain: insights from recent anatomical and functional studies. Adv Exp Med Biol 612:119-137. doi:10.1007/978- 0-387-74672-2-9
59. McGowan BM, Stanley SA, Smith KL, White NE, Connolly MM, Thompson EL, Gardiner JV, Murphy KG, Ghatei MA, Bloom SR (2005) Central relaxin-3 administration causes hyperphagia in male Wistar rats. Endocrinology 146:3295-3300. doi:10.1210/ en.2004-1532 (Pubitemid 41058100)
60. Min G, Sherwood OD (1996) Identification of specific relaxin-binding cells in the cervix, mammary glands, nipples, small intestine, and skin of pregnant pigs. Biol Reprod 55:1243-1252. doi: 10.1095/biolreprod55.6.1243 (Pubitemid 26398867)
61. Montie J, Pienta K (1994) Review of the role of androgenic hormones in the epidemiology of benign prostatic hyperplasia and prostate cancer. Urology 43:892-899
62. Nomura A, Heilbrun LK, Stemmermann GN, Judd HL (1988) Prediagnostic serum hormones and the risk of prostate cancer. Cancer Res 48:3515-3517
63. ODay MB, Winn RJ, Easter RA, Dzuik PJ, Sherwood OD (1989) Hormonal control of the cervix in pregnant gilts. II. Relaxin promotes changes in the physical properties of the cervix in ovariectomized hormone-treated pregnant gilts. Endocrinology 125:3004-3010. doi:10.1210/endo-125-6-3004 (Pubitemid 20010676)
64. Park J, Chang C, Hsu S (2005) New Insights into biological roles of relaxin and relaxin-related peptides. Rev Endocr Metab Disorders 6:291-296. doi:10.1007/s11154-005-6187-x (Pubitemid 41719988)
65. Pupula M, Quinn P, Maclennan A (1986) The effect of porcine relaxin on the fertilisation of mouse oocytes in vitro. Clin Reprod Fertil 4:383-387 (Pubitemid 18013284)
66. Sacchi TB, Bani D, Brandi ML, Falchetti A, Bigazzi M (1994) Relaxin influences growth, differentiation and cell-cell adhesion of human breast-cancer cells in culture. Int J Cancer 57:129-134. doi:10.1002/ijc.2910570123 (Pubitemid 24117112)
67. Samuel CS (2005) Relaxin: antifibrotic properties and effects in models of disease. Clin Med Res 3:241-249
68. Samuel CS, Unemori EN, Mookerjee I, Bathgate RAD, Layfield SL, Mak J, Tregear GW, Du X-J (2004) Relaxin modulates cardiac fibroblast proliferation, differentiation, and collagen production and reverses cardiac fibrosis in vivo. Endocrinology 145:4125-4133. doi:10.1210/en.2004-0209 (Pubitemid 39120561)
69. Samuel CS, Du XJ, Bathgate RAD, Summers RJ (2006) 'Relaxin the stiffened heart and arteries: the therapeutic potential for relaxin in the treatment of cardiovascular disease. Pharm Ther 112:529-552. doi:10.1016/j.pharmthera.2005. 05.012 (Pubitemid 44486415)
70. Shabanpoor F, Separovic F, Wade JD (2009) The human insulin superfamily of polypeptide hormones. Vitam Horm 80:1-31. doi:10.1016/s0083-6729(08)00601-8
71. Shabanpoor F, Hughes RA, Zhang S, Bathgate RAD, Layfield S, Hossain MA, Tregear GW, Separovic F, Wade JD (2010) Effect of helix-promoting strategies on the LGR8 receptor activity of novel analogues of the B-chain of human insulin-like peptide 3, INSL3. Amino Acids 38:121-131. doi:10.1007/s00726-008- 0219-2
72. Sherwood OD (2004) Relaxins physiological roles and other diverse actions. Endocr Rev 25:205-234. doi:10.1210/er.2003-0013 (Pubitemid 38501394)
73. Sherwood CD, OByrne EM (1974) Purification and characterization of porcine relaxin. Arch Biochem Biophys 160:185-196. doi: 10.1016/s0003-9861(74) 80025-1
74. Silvertown JD, Geddes BJ, Summerlee AJ (2003) Adenovirusmediated expression of human prorelaxin promotes the invasive potential of canine mammary cancer cells. Endocrinology 144:3683-3691. doi:10.1210/en.2003-0248 (Pubitemid 36904448)
75. Silvertown JD, Ng J, Sato T, Summerlee AJ, Medin JA (2006) H2 relaxin overexpression increases in vivo prostate xenograft tumor growth and angiogenesis. Int J Cancer 118:62-73. doi: 10.1002/ijc.21288 (Pubitemid 41681581)
76. Silvertown JD, Symes JC, Neschadim A, Nonaka T, Kao JCH, Summerlee AJ, Medin JA (2007) Analog of H2 relaxin exhibits antagonistic properties and impairs prostate tumor growth. FASEB J 21:754-765. doi:10.1096/fj.06-6847com (Pubitemid 46348251)
77. Sokol RZ, Wang XS, Lechago J, Johnston PD, Swerdloff RS (1989) Immunohistochemical localization of relaxin in human prostate. J Histochem Cytochem 37:1253-1255. doi:10.1177/ 37.8.2666509 (Pubitemid 19186026)
78. Teerlink JR, Metra M, Felker MG, Ponikowski P, Voors AA, Weatherley BD, Marmor A, Katz A, Grzybowski J, Unemori E, Teichman SL, Cotter G (2009) Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): a multicentre, randomised, placebo-controlled, parallel-group, dosefinding phase IIb study. Lancet 373:1429-1439. doi:10.1016/ s0140-6736(09)60622-x
79. Unemori EN, Amento EP (1990) Relaxin modulates synthesis and secretion of procollagenase and collagen by human dermal fibroblasts. J Biol Chem 265:10681-10685
80. Unemori EN, Pickford LB, Salles AL, Piercy CE, Grove BH, Erikson ME, Amento EP (1996) Relaxin induces an extracellular matrixdegrading phenotype in human lung fibroblasts in vitro and inhibits lung fibrosis in a murine model in vivo. J Clin Investig 98:2739-2745. doi:10.1172/jci119099 (Pubitemid 26427400)
81. Vinall RL, Tepper CG, Shi XB, Xue LA, Gandour-Edwards R, de Vere White RW (2006) The R273H p53 mutation can facilitate the androgen-independent growth of LNCaP by a mechanism that involves H2 relaxin and its cognate receptor LGR7. Oncogene 25:2082-2093
82. Weiss G (1989) Relaxin in the male. Biol Reprod 40:197. doi: 10.1095/biolreprod40.2.197 (Pubitemid 19104227)
83. Wilkinson T (2005) Coevolution of the relaxin-like peptides and their receptors. Ann N Y Acad Sci 1041:534-539. doi:10.1196/annals. 1282.080 (Pubitemid 41132297)
84. Willcox J, Summerlee A (2010) RLN2 and its role in cancer. In: Huret J (ed) Atlas of genetics and cytogenetics in oncology and haematology. INIST-CNRS, France, pp 1768-3262
85. Winn RJ, Baker MD, Merle CA, Sherwood OD (1994) Individual and combined effects of relaxin, estrogen, and progesterone in ovariectomized gilts. II. Effects on mammary development. Endocrinology 135:1250-1255. doi:10.1210/en.135.3.1250 (Pubitemid 24271223)
86. Zhang W-J, Luo X, Liu Y-L, Shao X-X, Wade JD, Bathgate RAD, Guo Z-Y (2012) Site-specific DOTA/europium-labeling of the recombinant human relaxin-3 for receptor-ligand interaction. Amino Acids 43:983-992
87. Zhu J, Kuei C, Sutton S, Kamme F, Yu J, Bonaventure P, Atack J, Lovenberg TW, Liu C (2008) Identification of the domains in RXFP4 (GPCR142) responsible for the high affinity binding and agonistic activity of INSL5 at RXFP4 compared to RXFP3 (GPCR135). Eur J Pharmacol 590:43-52. doi:10.1016/j.ejphar. 2008.05.025
88. Ziel HK (2000) Historical note Frederick L. Hisaw (1891-1972) and the discovery of relaxin. Endocrinologist 10:215218. doi: 10.1097/00019616- 200010040-00001